This unique tumor microenvironment composition of EBV(+) DLBCL with a relative increase in inflammatory cells, CD8(+) T-cells, and reduced B-cells has been confirmed by multiple studies [76,77,78]. The gene discussed is CD8A; the disease is neoplasm.